Amid Historic Glut Of Lab Space, Big-Name Developers Teeing Up New Projects

Barchart · 07/02 03:24
Between the excess of life sciences lab space on the market today and significant federal funding cuts threatening support for core research, most biotech builders aren’t in expansion mode.  Which makes it all the more interesting that developers have moved forward on a trio of major mixed-use developments — including two featuring Houston-based giant Hines — in the past three months with a strong focus on life sciences. “These developers seem to share the conviction that the life sciences market will eventually recover,” JLL National Life Sciences Research Director Mark Bruso said. “There is a clear indication from tenants that they want to be in core, well-amenitized markets...